NO20051082L - Antimikrobielle kinoloner, deres sammensetninger og anvendelser - Google Patents

Antimikrobielle kinoloner, deres sammensetninger og anvendelser

Info

Publication number
NO20051082L
NO20051082L NO20051082A NO20051082A NO20051082L NO 20051082 L NO20051082 L NO 20051082L NO 20051082 A NO20051082 A NO 20051082A NO 20051082 A NO20051082 A NO 20051082A NO 20051082 L NO20051082 L NO 20051082L
Authority
NO
Norway
Prior art keywords
compositions
applications
antimicrobial quinolones
quinolones
antimicrobial
Prior art date
Application number
NO20051082A
Other languages
English (en)
Norwegian (no)
Inventor
Benoit Ledoussal
Ji-In Kim Almstead
Jeffrey Lyle Gray
Xiufeng Eric Hu
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20051082L publication Critical patent/NO20051082L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20051082A 2002-07-31 2005-02-28 Antimikrobielle kinoloner, deres sammensetninger og anvendelser NO20051082L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40001402P 2002-07-31 2002-07-31
PCT/US2003/022587 WO2004014893A2 (fr) 2002-07-31 2003-07-18 Quinolones anti-microbiens, leurs compositions et utilisation

Publications (1)

Publication Number Publication Date
NO20051082L true NO20051082L (no) 2005-04-29

Family

ID=31715691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051082A NO20051082L (no) 2002-07-31 2005-02-28 Antimikrobielle kinoloner, deres sammensetninger og anvendelser

Country Status (17)

Country Link
US (1) US6900224B2 (fr)
EP (1) EP1532137A2 (fr)
JP (1) JP2005536532A (fr)
KR (1) KR20050026074A (fr)
CN (1) CN1671690A (fr)
AU (1) AU2003259169A1 (fr)
BR (1) BR0313420A (fr)
CA (1) CA2493146A1 (fr)
IL (1) IL166041A0 (fr)
MA (1) MA27467A1 (fr)
MX (1) MXPA05001180A (fr)
NO (1) NO20051082L (fr)
NZ (1) NZ537203A (fr)
PL (1) PL375388A1 (fr)
RU (1) RU2005105337A (fr)
WO (1) WO2004014893A2 (fr)
ZA (1) ZA200500877B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE128799A1 (es) * 1997-09-15 2000-02-17 Procter & Gamble Quinolinas antimicrobianas y sus composiciones
CN1414856A (zh) * 1999-12-28 2003-04-30 帝国制药株式会社 治疗瘙痒的外用制剂
WO2004091627A2 (fr) * 2003-04-07 2004-10-28 Cylene Pharmaceuticals, Inc. Analogues heterocycliques de 1,4-dihydro-4-oxo-1,8-naphthpyridine substitues
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
US7354916B2 (en) * 2003-04-07 2008-04-08 Cylene Pharmaceuticals Substituted quinobenzoxazine analogs
EP1610759A4 (fr) * 2003-04-07 2007-04-25 Cylene Pharmaceuticals Inc Analogues de quinobenzoxazine substitues
AU2005286965B2 (en) * 2004-09-17 2009-10-22 Senhwa Biosciences, Inc. Quinolone analogs as cell proliferation inhibitors
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
US7456279B2 (en) * 2006-03-28 2008-11-25 The Procter & Gamble Company Coupling process for preparing quinolone intermediates
PL2001862T3 (pl) * 2006-03-28 2011-09-30 Warner Chilcott Co Llc Jabłczany oraz odmiany polimorficzne kwasu (3S,5S)-7-[3-amino-5-metylo-piperydynylo]-1-cyklopropylo-1,4-dihydro-8-metoksy-4-okso-3-chinolinokarboksylowego
WO2007110836A1 (fr) * 2006-03-28 2007-10-04 The Procter & Gamble Company Procédé de réduction par un hydrure servant à préparer des intermédiaires de quinolones
US7723355B2 (en) * 2006-11-20 2010-05-25 Bristol-Myers Squibb Company 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
BRPI0817806A2 (pt) 2007-10-05 2014-10-07 Cylene Pharmaceuticals Inc Análogos de quinolona e métodos relacionados a estes
NZ588898A (en) * 2008-07-01 2012-09-28 Taigen Biotechnology Co Ltd Use of nemonoxacin for treating antibiotic-resistant staphylococcus aureus infection
CN101618039B (zh) * 2008-07-02 2012-04-11 太景生物科技股份有限公司 肺炎的治疗药物
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
EP2376477A4 (fr) * 2008-12-15 2012-08-08 Taigen Biotechnology Co Ltd Synthèse stéréosélective de dérivés de pipéridine
CN102093260B (zh) * 2009-12-14 2014-03-05 太景生物科技股份有限公司 哌啶衍生物的立体有择合成
JP7017509B2 (ja) 2015-11-20 2022-02-08 センワ バイオサイエンシズ インコーポレイテッド がんを治療するための四環式キノロン類似体の併用療法
US9957282B2 (en) 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
ES2789756T3 (es) 2015-12-23 2020-10-26 Merck Sharp & Dohme Moduladores alostéricos de 6,7-dihidro-5H-pirrolo[3,4-b]piridin-5-ona del receptor de acetilcolina muscarínico M4
WO2017107089A1 (fr) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. Modulateurs allostériques 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
WO2018112843A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther hétéroarylpipéridine du récepteur muscarinique de l'acétylcholine m4
WO2018112842A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther hétéroarylpipéridine 6,6-fusionné du récepteur muscarinique de l'acétylcholine m4
WO2018112840A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther d'hétéroarylpipéridine 6, 5-fusionnés du récepteur muscarinique d'acétylcholine m4
WO2019000238A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 5-(pyridin-3-yl)oxazole du récepteur muscarinique m4 de l'acétylcholine
WO2019000236A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
WO2019000237A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
JP7445597B2 (ja) 2018-02-15 2024-03-07 センワ バイオサイエンシズ インコーポレイテッド キノロン類似体及びそれらの塩、組成物、ならびにそれらの使用方法
PE20201257A1 (es) * 2018-04-25 2020-11-16 Bayer Animal Health Gmbh Proceso para la hidrolisis de esteres carboxilicos de quinolona

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2070142T3 (es) 1988-05-19 1995-06-01 Chugai Pharmaceutical Co Ltd Nuevos derivados del acido quinolonacarboxilico.
ATE217309T1 (de) * 1993-10-14 2002-05-15 Abbott Lab Verbindungen des chinolizinon-typs
AU6153096A (en) * 1995-06-06 1996-12-24 Abbott Laboratories Quinolizinone type compounds
KR100241673B1 (ko) * 1997-08-09 2000-03-02 김충섭 퀴놀리진 카르복실산 유도체
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
PE128799A1 (es) * 1997-09-15 2000-02-17 Procter & Gamble Quinolinas antimicrobianas y sus composiciones
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
JP4811978B2 (ja) * 2000-01-24 2011-11-09 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 3−アミノキナゾリン−2,4−ジオン抗菌剤
AU3089102A (en) 2000-12-14 2002-06-24 Procter & Gamble Antimicrobial quinolones

Also Published As

Publication number Publication date
RU2005105337A (ru) 2006-01-20
US6900224B2 (en) 2005-05-31
BR0313420A (pt) 2005-06-28
KR20050026074A (ko) 2005-03-14
WO2004014893A3 (fr) 2004-04-08
IL166041A0 (en) 2006-01-15
NZ537203A (en) 2007-02-23
PL375388A1 (en) 2005-11-28
EP1532137A2 (fr) 2005-05-25
WO2004014893A2 (fr) 2004-02-19
ZA200500877B (en) 2006-02-20
MXPA05001180A (es) 2005-05-16
AU2003259169A1 (en) 2004-02-25
CN1671690A (zh) 2005-09-21
MA27467A1 (fr) 2005-08-01
US20040038975A1 (en) 2004-02-26
CA2493146A1 (fr) 2004-02-19
JP2005536532A (ja) 2005-12-02

Similar Documents

Publication Publication Date Title
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
CY1106958T1 (el) Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
NO20062892L (no) 7-fenylalkyl-substituert 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
SE0102315D0 (sv) Compounds
NO20044995L (no) Heterosykliske forbindelser
ATE413388T1 (de) Muskarin antagonisten
DK1432705T3 (da) Antibiotika med dobbeltvirkning
ATE511352T1 (de) Antimikrobielle zusammensetzungen
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
NO20064415L (no) Nye amido-substituerte hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
DE60321594D1 (de) Synergistische zusammensetzungen
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
DK1095059T3 (da) Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse
NO20030500L (no) Dihydroporfyrinderivater og deres anvendelse
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
DK1648906T3 (da) Organo-silicium-forbindelser og deres anvendelse
ATE348803T1 (de) Tryptase-inhibitoren
UY27311A1 (es) Agentes antibacterianos
NO20053562L (no) Nye aminobenzofenonforbindelser
ATE364037T1 (de) Tryptasehemmer
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application